Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine and Rituximab in Relapsed/Refractory Aggressive B-Cell NHL
NCT00385125Phase 2Unknown
- Sponsor
- University of Magdeburg
- Start
- Aug 2004
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine, rituximab in B-cell non-Hodgkin lymphoma, sponsored by University of Magdeburg. Status: unknown.
02
Drugs
bendamustinerituximab
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00385125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385125.